Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients

This study has been completed.
Jiangsu HengRui Medicine Co., Ltd.
Information provided by (Responsible Party):
Xichun Hu, Fudan University Identifier:
First received: July 20, 2010
Last updated: September 8, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):